Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
19993.5%EBITDA Margin
VS
Market
Sector
Industry
History
$ 5.53Close
$ 4.18 - $ 7.23 52-Week Range
Ticker Information
Ticker
ABEOCompany Name
ABEONA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQABEONA THERAPEUTICS INC - EBITDA Margin Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
ABEO - EBITDA % Historical data
| Date | Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | EBITDA Margin | Revenues |
|---|---|---|---|
| 6/30/2025 | $ 79.97M | 19993.5% | $ 400K |
| 3/31/2025 | $ -36.93M | 0% | $ 0 |
| 12/31/2024 | $ -56.62M | 0% | $ 0 |
| 9/30/2024 | $ -64.94M | 0% | $ 0 |
| 6/30/2024 | $ -47.48M | 0% | $ 0 |
| 3/31/2024 | $ -72.36M | -2067.31% | $ 3.5M |
| 12/31/2023 | $ -50.57M | -1444.91% | $ 3.5M |
| 9/30/2023 | $ -34.75M | -973.93% | $ 3.57M |
| 6/30/2023 | $ -32.01M | -897.2% | $ 3.57M |
| 3/31/2023 | $ -22.91M | -2144.85% | $ 1.07M |
Key Performance Insights, Last 5 Years
- ABEONA THERAPEUTICS INC's latest trailing twelve months (TTM) EBITDA % stands at -1061.17%.
- Over the past 5 years, ABEONA THERAPEUTICS INC's average EBITDA % has been -173.08%.
- The median EBITDA % for ABEONA THERAPEUTICS INC during this period was -1467.77%
- ABEONA THERAPEUTICS INC reached its highest EBITDA % over the past 5 years at 19993.5%.
- The lowest EBITDA % recorded by ABEONA THERAPEUTICS INC in the same timeframe -2560.07%
ABEONA THERAPEUTICS INC's EBITDA % vs. competitors
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBITDA % Benchmarks
Similar metrics to Revenues:
- EBIT Margin - [Calculation] A company’s [EBIT] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest and taxes.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Free Cash Flow Margin - [Calculation] A company’s Free Cash Flow [FCF] as a percentage of [Revenue]. Measures how much cash a company produces for each dollar of revenue generated.
- Enterprise Value over EBITDA - [Calculation] Measures a company’s Enterprise Value [EV] in relation to its earnings before interest, taxes, depreciation, and amortization [EBITDA].
- Revenues - [Income Statement] The sum of revenue generated from all sold goods and rendered services.
Definition of EBITDA Margin
[Calculation] A company’s [EBITDA] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated before interest, taxes, depreciation and amortization.EBITDA / Revenues
(=) EBITDA % EBITDA % for ABEONA THERAPEUTICS INC is calculated as follows: EBITDA [ $ -74.28M ] / Revenues [ $ 7M ]
(=) EBITDA % [ -1061.17% ] ABEO - EBITDA Margin, Last 5 years
-2560.07%
Minimum
Dec 31, 2021
19993.5%
Maximum
Jun 30, 2025
-173.08%
Average
-1467.77%
Median
EBITDA % Benchmark AnalysisMarket
The chart above depicts the distribution of EBITDA % for companies in the Total Stock Market. The average EBITDA % of the companies is 16.15% with a standard deviation of 26.84%.
The following table provides additional summary stats:
EBITDA % in the Market:
| filtered constituents | 3.29K |
|---|---|
| min | -74.98% |
| max | 97.73% |
| average | 16.15% |
| median | 14.67% |
| std | 26.84% |